Vitamin D potentiates the inhibitory effect of MicroRNA-130a in hepatitis C virus replication independent of type I interferon signaling pathway

9Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Calcitriol, the bioactive metabolite of vitamin D, was reported to inhibit HCV production in a synergistic fashion with interferon, a treatment in vitro. Our previous study established that miR-130a inhibits HCV replication by restoring the host innate immune response.We aimed to determine whether there is additive inhibitory effect of calcitriol and miR-130a onHCV replication.Here we showed that calcitriol potentiates the anti-HCVeffect of miR-130a in both Con1b replicon and J6/JFH1 culture systems. Intriguingly, this potentiating effect of calcitriol on miR-130a was not through upregulating the expression of cellular miR-130a or through increasing the miR-130a-mediated IFNα/β production. All these findings may contribute to the development of novel anti-HCV therapeutic strategies although the antiviral mechanism needs to be further investigated.

Cite

CITATION STYLE

APA

Duan, X., Guan, Y., Li, Y., Chen, S., Li, S., & Chen, L. (2015). Vitamin D potentiates the inhibitory effect of MicroRNA-130a in hepatitis C virus replication independent of type I interferon signaling pathway. Mediators of Inflammation, 2015. https://doi.org/10.1155/2015/508989

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free